WHO chief rejects U.S. justification for withdrawal as harmful to global health

World Health Organization Director-General Dr. Tedros Adhanom Ghebreyesus on Sunday publicly rejected the U.S. government’s stated reasons for formally withdrawing from the WHO, calling the explanations "untrue" and warning that the departure risks undermining global health coordination. The announcement crystallizes a rupture between Washington and the U.N. agency at a moment when international disease surveillance and pandemic preparedness remain fragile.

The administration’s formal exit, effective today, removes the United States from the multilateral body that coordinates cross-border public health responses, sets technical standards and channels funding for disease control programs worldwide. Dr. Tedros used a public statement and press engagements over Jan. 24–25 to contest the U.S. account and to emphasize the operational consequences of severing ties.

WHO officials declined to release verbatim transcripts of private talks with U.S. counterparts, but Dr. Tedros framed the dispute as one of facts rather than philosophy, asserting that the explanations offered by Washington did not match the agency’s record and performance. He also outlined broad concerns about the immediate effects of the exit on joint programs, data sharing and emergency responses, arguing that diminished collaboration will make it harder to detect and contain outbreaks early.

The United States’ decision closes a chapter of long-standing engagement in the WHO that included financing technical assistance, contributing to vaccine distribution mechanisms and participating in international surveillance networks. While the agency will continue its work, the withdrawal creates a budgetary and operational gap: WHO relies on assessed contributions from member states and large voluntary funds that support priority programs in low- and middle-income countries. A sudden reduction in U.S. engagement is likely to compel the organization to reallocate resources, seek new donors and reconsider program priorities.

Global health experts say the practical implications could be severe even if formal cooperation mechanisms remain in place through other channels. Laboratories that rely on shared platforms for pathogen sequencing, regional emergency operations that coordinate cross-border responses and procurement channels for vaccines and diagnostics all depend on multilateral architectures in which the United States has played a central role. Without Washington at the table, those systems face increased fragmentation and potential delays during crises.

The move also shifts diplomatic dynamics. The WHO will need to navigate donor politics while preserving its technical independence and trust among member states. Member countries now face decisions about whether to step up funding, deepen regional collaborations or pursue bilateral arrangements to fill gaps. For many public health officials, the priority will be maintaining continuity of surveillance and supply chains for essential medicines and vaccines.

Dr. Tedros concluded his public remarks by urging continued international cooperation on public health fundamentals, stressing that infectious diseases do not respect borders and that shared capacities benefit every country. As the practical effects of the U.S. withdrawal unfold, health ministries, global funders and civil society groups will be watching for changes in program funding, data flows and emergency response readiness that could influence preparedness for the next pandemic.